Literature DB >> 32860591

GABAB Receptors: Anxiety and Mood Disorders.

Daniela Felice1,2, John F Cryan3,4, Olivia F O'Leary5,6.   

Abstract

Gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain, acts at the ionotropic GABAA and GABAC receptors, and the metabotropic GABAB receptor. This chapter summarizes the studies that have investigated the role of the GABAB receptor in stress-related psychiatric disorders including anxiety and mood disorders. Overall, clinical and preclinical evidences strongly suggest that the GABAB receptor is a therapeutic candidate for depression and anxiety disorders. However, the clinical development of GABAB receptor-based drugs to treat these disorders has been hampered by their potential side-effects, particularly those of agonists. Nevertheless, the discovery of novel GABAB receptor allosteric modulators, and increasing understanding of the influence of specific intracellular GABAB receptor-associated proteins on GABAB receptor activity, may now pave the way towards GABAB receptor therapeutics in the treatment of mood and anxiety disorders.
© 2020. Springer Nature Switzerland AG.

Entities:  

Keywords:  Anxiety; Depression; GABAB receptor; Hippocampal neurogenesis; Mood; Stress; Stress resilience

Mesh:

Substances:

Year:  2022        PMID: 32860591     DOI: 10.1007/7854_2020_171

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  105 in total

1.  Autoradiographic study of degenerative and regenerative proliferation of neuroglia cells with tritiated thymidine.

Authors:  J ALTMAN
Journal:  Exp Neurol       Date:  1962-04       Impact factor: 5.330

2.  Are new neurons formed in the brains of adult mammals?

Authors:  J ALTMAN
Journal:  Science       Date:  1962-03-30       Impact factor: 47.728

Review 3.  Molecular structure and physiological functions of GABA(B) receptors.

Authors:  Bernhard Bettler; Klemens Kaupmann; Johannes Mosbacher; Martin Gassmann
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

4.  Epigenetic regulation of dorsal raphe GABA(B1a) associated with isolation-induced abnormal responses to social stimulation in mice.

Authors:  Ryota Araki; Yosuke Hiraki; Shoji Nishida; Nobuyuki Kuramoto; Kinzo Matsumoto; Takeshi Yabe
Journal:  Neuropharmacology       Date:  2015-09-11       Impact factor: 5.250

Review 5.  The potential efficacy of GABAB antagonists in depression.

Authors:  Robert C Alexander
Journal:  Curr Opin Pharmacol       Date:  2017-08-11       Impact factor: 5.547

Review 6.  Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence.

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Effects of baclofen on anxiety, sexual motivation, and olfactory perception in male mice in different psychoemotional states.

Authors:  A V Amikishieva; S N Semendyaeva
Journal:  Neurosci Behav Physiol       Date:  2007-11

Review 8.  CGP7930: a positive allosteric modulator of the GABAB receptor.

Authors:  C L Adams; A J Lawrence
Journal:  CNS Drug Rev       Date:  2007

Review 9.  Efficacy and tolerability of baclofen in substance use disorders: a systematic review.

Authors:  Roberta Agabio; Antonio Preti; Gian Luigi Gessa
Journal:  Eur Addict Res       Date:  2013-06-15       Impact factor: 3.015

10.  Effect of baclofen, a GABAB-agonist, on forced swimming-induced immobility in mice.

Authors:  K O Aley; S K Kulkarni
Journal:  Arch Int Pharmacodyn Ther       Date:  1990 Sep-Oct
View more
  1 in total

Review 1.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.